InsiderClue
Insiders · Profile

Stejbach Mark

Director at Indivior Pharmaceuticals · SVP/Chief Comm Off, Alks Inc at Alkermes. Filing since 13 Nov 2012. CIK 0001487937

INDV Indivior Pharmaceuticals, Inc. Director · 1 trade ALKS Alkermes plc. SVP/Chief Comm Off, Alks Inc · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
INDV Indivior Pharmaceuticals, Inc.
5 Jan 2026
Director
Bought on a plan
775
$27.43K
4.8%
ALKS Alkermes plc.
16 Feb 2018
SVP/Chief Comm Off, Alks Inc
Sold, plan not stated
10,880
$767.09K
19.8%
ALKS Alkermes plc.
8 Jun 2017
SVP/Chief Comm Off, Alks Inc
Sold, plan not stated
10,000
$603.35K
18.5%
ALKS Alkermes plc.
9 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold, plan not stated
547
$32.97K
1.6%
ALKS Alkermes plc.
6 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold, plan not stated
6,653
$399.64K
16.3%
ALKS Alkermes plc.
5 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold, plan not stated
300
$18.03K
0.9%
ALKS Alkermes plc.
4 Jan 2017
SVP/Chief Comm Off, Alks Inc
Sold, plan not stated
2,500
$150.02K
6.8%
ALKS Alkermes plc.
28 Dec 2015
Chief Commercial Officer
Sold, plan not stated
10,000
$802.39K
33.8%
ALKS Alkermes plc.
1 Dec 2015
Chief Commercial Officer
Sold, plan not stated
18,000
$1.30M
47.9%
ALKS Alkermes plc.
2 Nov 2015
Chief Commercial Officer
Sold, plan not stated
18,000
$1.30M
47.4%
ALKS Alkermes plc.
13 Nov 2012
Chief Commercial Officer
Bought
1,200
$24.16K
600%
11 decisions on file.